Answers are grounded in this paper and cite their sources.
Background Autosomal recessive bestrophinopathy (ARB) is a rare inherited retinal disorder caused by pathogenic variants in BEST1 gene and characterized by variable retinal structural and functional abnormalities. Data from Middle Eastern populations, including Egyptians, remain limited. Methods This retrospective observational case series included 30 patients from 19 consanguineous Egyptian families with a phenotype consistent with ARB and disease-causing variants in BEST1 gene. All patients underwent ophthalmological evaluation, with color photography, fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT). Phenotypes based on color and FAF were stratified into 7 types. Full-field electroretinogram (ffERG) and electrooculogram (EOG) were conducted. Molecular testing via bidirectional Sanger sequencing of BEST1 gene was performed. Results The mean age was 21.8 years. BCVA ranged from counting fingers to 20/20 with a mean of 20/63. Amplitudes of ffERGs were reduced in 89.7% and were within normal range in 10.3%. Most prevalent FAF phenotypes were Type I and Type III and least prevalent were Type IV and Type VII. Outer retinal layer thickening was the most frequently observed SD-OCT feature in 86.7% followed by subretinal fluid and intraretinal fluid observed in 80% while subretinal gliosis was observed in only 18.3%. Homozygous variants were identified in 29 patients and compound heterozygous variants in one patient. Eleven different variants were detected, two (18%) of which were novel. Conclusion Our study delineated phenotypes and the genetic landscape in ARB in an understudied population. ARB exhibited a marked phenotypic variability, with complex genotype-phenotype correlation, expanding current knowledge of ARB. Exons 2 and 4 were found to encompass mutational hotspots which could represent a useful finding in testing patients manifesting ARB preliminary through Sanger sequencing of these two exons. Moreover, the prevalence of R122P variant noted in 23/60 alleles (38.3%) makes this variant an attractive candidate for future gene editing trials in Egyptian patients.
No takes yet. Share an insight, caveat, or question.
Tawfik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: